Cancer Epidemiology Biomarkers & Prevention, Vol 6, Issue 7 505-509, Copyright © 1997 by American Association for Cancer Research

ARTICLES

Urinary estrogen metabolites and breast cancer: a case-control study

GC Kabat, CJ Chang, JA Sparano, DW Sepkovie, XP Hu, A Khalil, R Rosenblatt and HL Bradlow
Department of Epidemiology and Social Medicine, Albert Einstein Cancer Center, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10467, USA.

Preliminary studies suggest that the estrogen metabolite 16 alpha-hydroxyestrone is associated with breast cancer, whereas 2-hydroxyestrone is not. However, epidemiological studies evaluating this relationship and taking established risk factors for breast cancer into account are lacking. The purpose of this study was to examine the association of the ratio of the urinary estrogen metabolites (2-hydroxyestrone and 16 alpha-hydroxyestrone) and of the individual metabolites with breast cancer. A spot urine sample, a brief history, and clinical data were collected from breast cancer cases (n = 42) and from women coming to the hospital for a routine mammogram or attending a free breast cancer screening (n = 64). 2-Hydroxyestrone and 16 alpha-hydroxyestrone were measured by enzyme immunoassay, and the estrogen metabolite ratio (EMR; 2-hydroxyestrone:16 alpha-hydroxyestrone) was computed. Cases and controls were similar in terms of age (mean age of cases, 53.8 +/- 15.1 years, versus 54.2 +/- 10.4 years for controls; P = 0.9) and demographics. Mean EMR was not associated with breast cancer overall (1.67 +/- 0.80 versus 1.72 +/- 0.66; P = 0.7). However, in postmenopausal women, the mean EMR was significantly lower in cases compared to controls (1.41 +/- 0.73 versus 1.81 +/- 0.71; P = 0.05). The multivariate adjusted odds ratios for the intermediate and lowest tertiles of the EMR relative to the highest among postmenopausal women were 9.73 (95% confidence interval, 1.27-74.84) and 32.74 (95% confidence interval, 3.36-319.09), respectively. The test for trend was highly significant (P = 0.003). Analyses of the individual metabolites indicated that 16 alpha-hydroxyestrone was a strong risk factor. The EMR did not show any consistent associations with age, race/ethnicity, age at first birth, parity, body mass index, family history of breast cancer, smoking, or alcohol intake. These data suggest a strong, inverse association of the EMR and a strong positive association of 16 alpha-hydroxyestrone with breast cancer in postmenopausal women. Larger studies are needed to confirm these results and to assess the relationship of the EMR and of the individual metabolites with breast cancer, with attention to menopausal status and clinical factors and with adjustment for known breast cancer risk factors.

This article has been cited by other articles:

				A. H. Eliassen, S. A. Missmer, S. S. Tworoger, and S. E. Hankinson Circulating 2-Hydroxy- and 16{alpha}-Hydroxy Estrone Levels and Risk of Breast Cancer among Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 2029 - 2035. [Abstract] [Full Text] [PDF]

				E. Bageman, C. Ingvar, C. Rose, and H. Jernstrom Coffee Consumption and CYP1A2*1F Genotype Modify Age at Breast Cancer Diagnosis and Estrogen Receptor Status Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 895 - 901. [Abstract] [Full Text] [PDF]

				J. M. Hamilton-Reeves, S. A. Rebello, W. Thomas, J. W. Slaton, and M. S. Kurzer Soy Protein Isolate Increases Urinary Estrogens and the Ratio of 2:16{alpha}-Hydroxyestrone in Men at High Risk of Prostate Cancer J. Nutr., October 1, 2007; 137(10): 2258 - 2263. [Abstract] [Full Text] [PDF]

				K. L. Campbell, K. C. Westerlind, V. J. Harber, G. J. Bell, J. R. Mackey, and K. S. Courneya Effects of Aerobic Exercise Training on Estrogen Metabolism in Premenopausal Women: A Randomized Controlled Trial Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 731 - 739. [Abstract] [Full Text] [PDF]

				C. E. Wood, T. C. Register, and J.M. Cline Soy isoflavonoid effects on endogenous estrogen metabolism in postmenopausal female monkeys Carcinogenesis, April 1, 2007; 28(4): 801 - 808. [Abstract] [Full Text] [PDF]

				I. M. Medina-Diaz, G. Arteaga-Illan, M. B. de Leon, B. Cisneros, A. Sierra-Santoyo, L. Vega, F. J. Gonzalez, and G. Elizondo Pregnane X Receptor-Dependent Induction of the CYP3A4 Gene by o,p'-1,1,1,-Trichloro-2,2-Bis (p-Chlorophenyl)ethane Drug Metab. Dispos., January 1, 2007; 35(1): 95 - 102. [Abstract] [Full Text] [PDF]

				A. E. Cribb, M. J. Knight, D. Dryer, J. Guernsey, K. Hender, M. Tesch, and T. M. Saleh Role of polymorphic human cytochrome p450 enzymes in estrone oxidation. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 551 - 558. [Abstract] [Full Text] [PDF]

				A. Wellejus, A. Olsen, A. Tjonneland, B. L. Thomsen, K. Overvad, and S. Loft Urinary Hydroxyestrogens and Breast Cancer Risk among Postmenopausal Women: A Prospective Study Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2137 - 2142. [Abstract] [Full Text] [PDF]

				L. Le Marchand, T. Donlon, L. N. Kolonel, B. E. Henderson, and L. R. Wilkens Estrogen Metabolism-Related Genes and Breast Cancer Risk: The Multiethnic Cohort Study Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1998 - 2003. [Abstract] [Full Text] [PDF]

				W.-H. Wu, L.-Y. Liu, C.-J. Chung, H.-J. Jou, and T.-A. Wang Estrogenic Effect of Yam Ingestion in Healthy Postmenopausal Women J. Am. Coll. Nutr., August 1, 2005; 24(4): 235 - 243. [Abstract] [Full Text] [PDF]

				G. Lurie, G. Maskarinec, R. Kaaks, F. Z. Stanczyk, and L. Le Marchand Association of Genetic Polymorphisms with Serum Estrogens Measured Multiple Times During a 2-Year Period in Premenopausal Women Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1521 - 1527. [Abstract] [Full Text] [PDF]

				C. Atkinson, C. L. Frankenfeld, and J. W. Lampe Gut Bacterial Metabolism of the Soy Isoflavone Daidzein: Exploring the Relevance to Human Health Experimental Biology and Medicine, March 1, 2005; 230(3): 155 - 170. [Abstract] [Full Text] [PDF]

				J. A. Nettleton, K. A. Greany, W. Thomas, K. E. Wangen, H. Adlercreutz, and M. S. Kurzer The Effect of Soy Consumption on the Urinary 2:16-Hydroxyestrone Ratio in Postmenopausal Women Depends on Equol Production Status but Is Not Influenced by Probiotic Consumption J. Nutr., March 1, 2005; 135(3): 603 - 608. [Abstract] [Full Text] [PDF]

				R. T. Falk, T. R. Fears, X. Xu, R. N. Hoover, M. C. Pike, A. H. Wu, A. M.Y. Nomura, L. N. Kolonel, D. W. West, D. W. Sepkovic, et al. Urinary Estrogen Metabolites and Their Ratio among Asian American Women Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 221 - 226. [Abstract] [Full Text] [PDF]

				J. H. Fowke, X.-O. Shu, Q. Dai, F. Jin, Q. Cai, Y.-T. Gao, and W. Zheng Oral Contraceptive Use and Breast Cancer Risk: Modification by NAD(P)H:Quinone Oxoreductase (NQO1) Genetic Polymorphisms Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1308 - 1315. [Abstract] [Full Text] [PDF]

				K. Vistisen, S. Loft, J. H. Olsen, S. Vallentin, S. Ottesen, F. R. Hirsch, and H. E. Poulsen Low CYP1A2 activity associated with testicular cancer Carcinogenesis, June 1, 2004; 25(6): 923 - 929. [Abstract] [Full Text] [PDF]

				C. Atkinson, J. W. Lampe, S. S. Tworoger, C. M. Ulrich, D. Bowen, M. L. Irwin, R. S. Schwartz, B. K. Rajan, Y. Yasui, J. D. Potter, et al. Effects of a Moderate Intensity Exercise Intervention on Estrogen Metabolism in Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 868 - 874. [Abstract] [Full Text] [PDF]

				H. Jernstrom, T.L. Klug, D.W. Sepkovic, H.L. Bradlow, and S.A. Narod Predictors of the plasma ratio of 2-hydroxyestrone to 16{alpha}-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups Carcinogenesis, May 1, 2003; 24(5): 991 - 1005. [Abstract] [Full Text] [PDF]

				S. E Kasim-Karakas, R. U Almario, L. Gregory, H. Todd, R. Wong, and B. L Lasley Effects of prune consumption on the ratio of 2-hydroxyestrone to 16{alpha}-hydroxyestrone Am. J. Clinical Nutrition, December 1, 2002; 76(6): 1422 - 1427. [Abstract] [Full Text] [PDF]

				S. E. McCann, K. B. Moysich, J. L. Freudenheim, C. B. Ambrosone, and P. G. Shields The Risk of Breast Cancer Associated with Dietary Lignans Differs by CYP17 Genotype in Women J. Nutr., October 1, 2002; 132(10): 3036 - 3041. [Abstract] [Full Text] [PDF]

				M. S. Kurzer Hormonal Effects of Soy in Premenopausal Women and Men J. Nutr., March 1, 2002; 132(3): 570S - 573. [Abstract] [Full Text] [PDF]

				E. Riza, I. dos Santos Silva, B. De Stavola, H. L. Bradlow, D. W. Sepkovic, D. Linos, and A. Linos Urinary Estrogen Metabolites and Mammographic Parenchymal Patterns in Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 627 - 634. [Abstract] [Full Text] [PDF]

				G. Ursin, M. Wilson, B. E. Henderson, L. N. Kolonel, K. Monroe, H.-P. Lee, A. Seow, M. C. Yu, F. Z. Stanczyk, and E. Gentzschein Do Urinary Estrogen Metabolites Reflect the Differences in Breast Cancer Risk between Singapore Chinese and United States African-American and White Women? Cancer Res., April 1, 2001; 61(8): 3326 - 3329. [Abstract] [Full Text]

				W. Zheng, F. Jin, L. A. Dunning, X.-O. Shu, Q. Dai, W.-Q. Wen, Y.-T. Gao, and J. L. Holtzman Epidemiological Study of Urinary 6{beta}-Hydroxycortisol to Cortisol Ratios and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., March 1, 2001; 10(3): 237 - 242. [Abstract] [Full Text]

				M. Clemons and P. Goss Estrogen and the Risk of Breast Cancer N. Engl. J. Med., January 25, 2001; 344(4): 276 - 285. [Full Text] [PDF]

				J. H. Fowke, C. Longcope, and J. R. Hebert Brassica Vegetable Consumption Shifts Estrogen Metabolism in Healthy Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., August 1, 2000; 9(8): 773 - 779. [Abstract] [Full Text]

				X. Xu, A. M. Duncan, K. E. Wangen, and M. S. Kurzer Soy Consumption Alters Endogenous Estrogen Metabolism in Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., August 1, 2000; 9(8): 781 - 786. [Abstract] [Full Text]

				C. J. Haggans, E. J. Travelli, W. Thomas, M. C. Martini, and J. L. Slavin The Effect of Flaxseed and Wheat Bran Consumption on Urinary Estrogen Metabolites in Premenopausal Women Cancer Epidemiol. Biomarkers Prev., July 1, 2000; 9(7): 719 - 725. [Abstract] [Full Text]

				J. L. Slavin Mechanisms for the Impact of Whole Grain Foods on Cancer Risk J. Am. Coll. Nutr., June 1, 2000; 19(90003): 300S - 307. [Abstract] [Full Text] [PDF]

				L.-J. W. Lu, M. Cree, S. Josyula, M. Nagamani, J. J. Grady, and K. E. Anderson Increased Urinary Excretion of 2-Hydroxyestrone but not 16{{alpha}}-Hydroxyestrone in Premenopausal Women during a Soya Diet Containing Isoflavones Cancer Res., March 1, 2000; 60(5): 1299 - 1305. [Abstract] [Full Text]

				R. T. Falk, S. C. Rossi, T. R. Fears, D. W. Sepkovic, A. Migella, H. Adlercreutz, J. Donaldson, H. L. Bradlow, and R. G. Ziegler A New ELISA Kit for Measuring Urinary 2-Hydroxyestrone, 16{{alpha}}-Hydroxyestrone, and Their Ratio: Reproducibility, Validity, and Assay Performance after Freeze-Thaw Cycling and Preservation by Boric Acid Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 81 - 87. [Abstract] [Full Text]

				X. Xu, A. M. Duncan, B. E. Merz-Demlow, W. R. Phipps, and M. S. Kurzer Menstrual Cycle Effects on Urinary Estrogen Metabolites J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 3914 - 3918. [Abstract] [Full Text]

				C.-S. Huang, H.-D. Chern, K.-J. Chang, C.-W. Cheng, S.-M. Hsu, and C.-Y. Shen Breast Cancer Risk Associated with Genotype Polymorphism of the Estrogen-metabolizing Genes CYP17, CYP1A1, and COMT: A Multigenic Study on Cancer Susceptibility Cancer Res., October 1, 1999; 59(19): 4870 - 4875. [Abstract] [Full Text] [PDF]

				G. Ursin, S. London, F. Z. Stanczyk, E. Gentzschein, A. Paganini-Hill, R. K. Ross, and M. C. Pike Urinary 2-Hydroxyestrone/16{alpha}-Hydroxyestrone Ratio and Risk of Breast Cancer in Postmenopausal Women J Natl Cancer Inst, June 16, 1999; 91(12): 1067 - 1072. [Abstract] [Full Text] [PDF]